The Global Clinical Trial Management Market to Develop at CAGR of 10.92% by 2028

Triton Market Research presents the Global Clinical Trial Management Market segmented by Product Type (Site-based CTM, Enterprise-based CTM), Deployment Mode (On-Premise Deployment, Web-based Deployment, Cloud-based Deployment), End-user (Clinical Research Organizations, Pharmaceutical & Biopharmaceutical Companies, Healthcare Providers), Component (Hardware, Services, Software), and Geography (North America, Asia-Pacific, Latin America, Middle East and Africa, Europe). The report further discusses the Market Summary, Industry Outlook, Market Scope, Key Insights, Porter's Five Forces Analysis, Market Attractiveness Index, Vendor Scorecard, Drivers, Restraints, Opportunities, Key Strategic Developments, Impact of COVID-19, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2021-2028).

Triton's report implies that the global market for clinical trial management is expected to propel at a CAGR of 10.92% over the estimated years 2021-2028.

Clinical trial management contains hardware, software, and services engaged in maintaining and managing high data volume derived from clinical trials conducted across various organizations. These systems offer several benefits to pharma companies to supervise and obtain data whenever needed.

Factors such as growth in clinical trials, along with outsourcing clinical trials for cost reduction, are opening multiple avenues for the development of the clinical trial management market worldwide. The technological advancements and rise in demand for better drugs with lesser side effects have led to an increase in the number of clinical trials globally. Here, the innovation in data management, AI, and biotechnology is also accelerating the discovery of novel treatments, increasing the need for more clinical trials. However, the lack of a skilled workforce, high cost of implementation, and concerns regarding the security of CTM systems are obstructing the global market's future growth.

North America holds the largest market for clinical trial management and is likely to continue its hold over the market till 2028. Over the years, there has been a considerable growth in the demand for clinical trial management, owing to the well-developed healthcare infrastructure across the region's nations. Moreover, an increase in the number of clinical trials further stimulates the studied market's progress across the region. In the US and Canada, the presence of several major pharma companies and growing awareness about the benefits of using CTM systems are another set of factors responsible for expanding the clinical trial management market within North America.

The distinguished companies thriving in the clinical trial management market comprise IBM Corporation, Advarra (Forte Research Systems Inc), Oracle Corporation, Medidata Solutions Inc, Parexel International Corporation, Veeva Systems Inc, Mednet Solutions Inc, Bio-Optronics Inc, Arisglobal LLC, and Bioclinica Inc.

The investment cost for the new market players is moderately high. Moreover, there is continual support from the government and other organizations to enhance the R&D sector. This suggests that the threat of new entrants is likely to be moderate. On the other hand, the demand for CTM is rising due to the increase in awareness about the benefits offered by these systems. Hence, the competition among the existing players is expected to remain relatively high.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.